Efforts are targeting areas believed to be contributors or key drivers of the challenged subspecialty workforce, including ...

Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan ...

Stem cells are thought to be developmentally primitive and rare in number. The ability of cells to differentiate along various lines is referred to as developmental potential. Hence the zygote is ...

Background: Primary care physicians, who manage the care of most children with asthma, often do not optimally assess disease control, prescribe asthma controller medications, or provide family asthma ...

Our curriculum is divided into 13 rotation blocks (4 weeks each) per academic year with a combination of outpatient, inpatient and subspecialty rotations. We offer selective or elective rotations in ...

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended ...

Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total ...

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric ...

Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven clinical -stage oncology company developing targeted therapies for cancer that are being advanced using its proprietary computational biology and ...